American Biotech Labs Receives New EPA Approvals

[Guest guest]

PRESS RELEASE

American Biotech Labs Receives New EPA ApprovalsTuesday November 28, 11:15 am ET

Fourth set of EPA approvals enables ABL, partly owned by Clifton Mining, to be used to treat black mold and other pathogens

ALPINE, UT, Nov. 28 /PRNewswire-FirstCall/ - Clifton Mining Company Inc. (OTC: CFTN - News) today announced that American Biotech Labs (ABL), a private company in which Clifton Mining owns a 23 percent interest, has just received its fourth set of EPA approvals. These approvals govern the use of ASAP-AGX-32® against additional pathogens. They broaden the range of bacteria for which this product is approved to and include yeasts and environmental fungi. The Nature of the Tests These most recent tests were exceptionally stringent. They involved using the ASAP-AGX-32® against high concentrations of a variety of pathogens to kill all colony forming units within 10 minutes. All tests were successful. Black Mold One of the most important new approvals was for environmental fungi, including black mold. Black mold is common in buildings throughout the U.S., and often causes upper respiratory tract infections. Black mold is notoriously difficult to kill, and to the best of ABL leadership's knowledge, ABL's ASAP-AGX-32® is the only non-toxic and non-irritating product that has received EPA approval for this use. "We believe our nano-silver product is an important non-toxic broad-spectrum anti-pathogenic," said Moeller, VP of marketing for ABL. "It is gratifying to receive additional approvals that extend the range of accepted use for this product, as we continue to work to further extend the range of applications for this technology, which is now backed by patent # 7135195." Clifton trades on the U.S. OTC: (CFTN). Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance.